Cholangiocarcinoma: 545 Clinical Trials, Page 5 of 6

Hide Studies Not Open or Pending


Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma

Condition(s):Advanced Cholangiocarcinoma; FGFR1 Gene Alteration Positive; FGFR2 Gene Alteration Positive; FGFR3 Gene Alteration Positive; IDH1 Gene Mutation; IDH1 NP_005887.2:p.R132C; IDH1 NP_005887.2:p.R132G; IDH1 NP_005887.2:p.R132H; IDH1 NP_005887.2:p.R132L; IDH1 NP_005887.2:p.R132S; Metastatic Cholangiocarcinoma; Unresectable CholangiocarcinomaLast Updated:October 18, 2019Not yet recruiting

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.